Cheelcare looks to Dave Jones to expand dealer and clinical network

TORONTO – Cheelcare, a manufacturer of assistive mobility devices, has appointed Dave Jones, who brings more than 30 years of executive sales and marketing experience in the complex rehab and durable medical equipment (DME) sectors, as director of U.S. sales. His career includes senior roles at Drive Medical, Mertis Healthcare, Quantum Rehab (Pride Mobility), Bodypoint and National Seating & Mobility (NSM), where he developed extensive relationships across providers, payers, manufacturers and group purchasing organizations. He has led national sales teams, managed continuing-education programs for assistive technology professionals (ATPs) and executed multi-channel growth strategies resulting in expanded product adoption and increased market penetration through the United States. "Dave's industry expertise and long-standing relationships with major rehabilitation networks will be instrumental as we scale our presence in the U.S. market," said Allan Boyd, vice president of growth at Cheelcare. "With the recent CMS coding change, and the soon-to-launch Curio, his network and knowledge of the U.S. market will help us accelerate adoption and ensure that more users can access our innovative solutions to enhance their mobility and independence." As director of U.S. sales, Jones will oversee the expansion of Cheelcare's dealer and clinical network across key regional markets, focusing on enhancing product availability and end-user support for the company's Companion power-assist device and the upcoming U.S. launch of its Curio robotic complex rehab power wheelchair. His appointment follows the recent Centers for Medicare & Medicaid Services (CMS) update to the language of power mobility coding (HCPCS E0986) that now opens the door for Companion to qualify for submission under approved funding categories, which will significantly improve access to reimbursement and expand opportunities for U.S. distribution.